Spruce Biosciences (SPRB) Insider Trading & Ownership $0.49 +0.01 (+2.10%) (As of 11/19/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Spruce Biosciences (NASDAQ:SPRB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$2.61 M Get SPRB Insider Trade Alerts Want to know when executives and insiders are buying or selling Spruce Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SPRB Insider Buying and Selling by Quarter Ad DTII've got news for you… Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekwatch this FREE briefing with me and expert trader Graham Lindman Spruce Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/20/2024Holdings A/S NovoMajor ShareholderSell359,979$0.73$262,784.67 3/18/2024Holdings A/S NovoMajor ShareholderSell842,020$0.77$648,355.40 3/14/2024Holdings A/S NovoMajor ShareholderSell1,912,316$0.89$1,701,961.24 (Data available from 1/1/2013 forward) SPRB Insider Trading Activity - Frequently Asked Questions Who is on Spruce Biosciences's Insider Roster? The list of insiders at Spruce Biosciences includes Holdings A/S Novo. Learn more on insiders at SPRB. What percentage of Spruce Biosciences stock is owned by insiders? 9.10% of Spruce Biosciences stock is owned by insiders. Learn more on SPRB's insider holdings. Which Spruce Biosciences insiders have been selling company stock? The following insider sold SPRB shares in the last 24 months: Holdings A/S Novo ($2,613,101.31). How much insider selling is happening at Spruce Biosciences? Insiders have sold a total of 3,114,315 Spruce Biosciences shares in the last 24 months for a total of $2,613,101.31 sold. Spruce Biosciences Key ExecutivesMr. Michael G. Grey (Age 71)Executive Chairman Compensation: $70kDr. Javier Szwarcberg M.D. (Age 54)M.P.H., CEO & Director Compensation: $951.85kMr. Samir M. Gharib CPA (Age 42)M.B.A., President & CFO Compensation: $683.63kDr. Ralph William Charlton III (Age 54)M.D., Chief Medical Officer Compensation: $647.4kMs. P. J. RamtinSenior Vice President of Business OperationsMs. Heidi Petersen M.P.H.Senior Vice President of Regulatory & Quality More Insider Trading Tools from MarketBeat Related Companies Eagle Pharmaceuticals Insider Trading CASI Pharmaceuticals Insider Trading PMV Pharmaceuticals Insider Trading Ikena Oncology Insider Trading Celularity Insider Trading Aileron Therapeutics Insider Trading Clearside Biomedical Insider Trading Metagenomi Insider Trading Cue Biopharma Insider Trading ESSA Pharma Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:SPRB) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spruce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spruce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
